NOS2 and Sepsis: Treatment with the selective iNOS inhibitor, aminoguanidine, inhibited sepsis-induced plasma nitrate/nitrite concentrations, reduced LPS-induced bacterial translocation by improving intestinal hyperpermeability, improved oxygen consumption rate, and prevented hypotension without affecting cardiac output.